logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Tesaro, Inc.

Calculating rank
USPTO Granted Patents = 18


Trademarks = 4

Forward Citations = 9

Loading Chart...
Loading Chart...

39 inventors (with patents filed for the assignee):

goldMedal George G Wu (5 out of 26 patents)

silverMedal Alistair Stewart (3 out of 3 patents)

bronzeMedal Zebin Wang (3 out of 3 patents)

4.  David Jenkins (2 out of 7 patents)

5.  Haley A Laken (2 out of 2 patents)

6.  Ellie Im (2 out of 2 patents)

7.  Allene Diaz (2 out of 2 patents)

8.  Sharon Lu (2 out of 2 patents)

9.  Marilyn Kehry (2 out of 14 patents)

10.  David J King (2 out of 54 patents)

11.  Anthony Joseph Toto (2 out of 2 patents)

12.  Frank Xing Chen (2 out of 22 patents)

13.  Baochuan Huang (2 out of 2 patents)

14.  John Chaber (2 out of 2 patents)

15.  Arlene E McKeown (2 out of 3 patents)


18 patents:

1. 12597519 - Methods for characterizing and treating a cancer type using cancer images (2026-04-07),
2. 12527780 - Methods of treating ovarian cancer (2026-01-20),
3. 12415855 - Methods of treating cancer with anti-PD-1 antibodies (2025-09-16),
4. 12383542 - Methods of treating ovarian cancer (2025-08-12),
5. 12297184 - Niraparib salts (2025-05-13),
6. 12156872 - Combination therapies for treating cancer (2024-12-03),
7. 11926665 - Methods of treating cancer with anti-TIM-3 antibodies (2024-03-12),
8. 11801240 - Combination therapies and uses thereof (2023-10-31),
9. 11753472 - Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3) (2023-09-12),
10. 11730725 - Niraparib formulations (2023-08-22),
11. 11673877 - Niraparib compositions (2023-06-13),
12. 11661453 - Combination therapies for treating cancer with niraparib and PD-1 inhibitors (2023-05-30),
13. 11629137 - Methods of manufacturing of niraparib (2023-04-18),
14. 11622961 - Combination therapies for treating cancer (2023-04-11),
15. 11407830 - Methods of treating cancer with anti-PD-1 antibodies (2022-08-09),
Company Overview
Tesaro, Inc., based in Waltham, Massachusetts, is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The organization specializes in the research and commercialization of novel oncology drugs, particularly in the areas of immuno-oncology and targeted therapies. Tesaro aims to improve patient outcomes through its commitment to advancing cancer care, leveraging cutting-edge science and technology to address unmet medical needs in oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#81 in Waltham, MA

#1,102 in Massachusetts

#17,980 in US

#34,263 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Tesaro, Inc.

Forward Citations = 9

39 inventors:

goldMedal George G Wu (5 out of 26 patents)

silverMedal Alistair Stewart (3 out of 3 patents)

bronzeMedal Zebin Wang (3 out of 3 patents)

4.  David Jenkins (2 out of 7 patents)

5.  Haley A Laken (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tesaro, Inc.. Retrieved from https://idiyas.com/company/tesaro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…